QualityStocksNewsBreaks Archives - Page 311 of 1424

WednesdayFeb 15, 2023 3:14 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) CEO Shares Insight on Control-Based Approach to Cybersecurity

SideChannel (OTCQB: SDCH), a cybersecurity services and technology provider, draws on years of experience in the sector to offer especially effective virtual chief information security officer (“vCISO”) solutions to its clients. A recent article covers an interview with the Cyber for Hire podcast during which SideChannel’s CEO Brian Haugli discussed the decisions that go into a successful working relationship between vCISOs and clients. During the discussion, Haugli provided an example in which a company trying to meet cybersecurity industry standards established by the National Institute of Standards and Technology Cybersecurity Framework identifies 10 gaps to address within 89 controls that…

WednesdayFeb 15, 2023 1:26 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Lead NanoAb Candidate Demonstrates Significant Advantages

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently achieved key milestones. These include the demonstration of statistically significant positive results from a preclinical in-vivo proof-of-concept study of its inhaled anti-COVID-19 nanosized antibodies (“NanoAbs”). “Its lead NanoAb candidate, designed to treat COVID-19, has exhibited significant competitive advantages over existing oral therapies and monoclonal antibodies (‘mAbs’),” a recent article reads. “In the aforementioned study, BiondVax found that COVID-19-infected Syrian hamsters treated with its inhaled anti-COVID-19 NanoAb candidate had an average weight loss of 3.80% compared…

WednesdayFeb 15, 2023 1:18 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc.’s Comprehensive Solution Can Produce All the Energy a Home Needs

GeoSolar Technologies (“GST”), a Colorado-based climate technology company, stands to benefit amid rising awareness of climate change and the increasing understanding that the overreliance on fossil fuels can have a detrimental economic impact on consumers. “GeoSolar appears well positioned to capitalize on the growing momentum across the country amid a push for green energy alternatives. With its SmartGreen(TM) holistic renewable energy systems that include rooftop photovoltaic solar panels and geothermal ground loops, GeoSolar works to help consumers capitalize on the power of the sun and earth to provide heating, air conditioning and electricity,” explains a recent article. “This innovative solution…

WednesdayFeb 15, 2023 12:04 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Completes Strategic Sale of Alta Mesa Project

Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced its completion of the sale of three wholly owned subsidiaries that together hold its Alta Mesa ISR Project to enCore Energy Corp. “Energy Fuels’ sale of the Alta Mesa project for $120 million of total consideration is highly strategic for a variety of reasons,” said UUUU CEO and President Mark S. Chalmers. “When combined with our already strong balance sheet, the proceeds from this sale are expected to fully fund our current uranium, vanadium and rare earth business plans through approximately 2024 without the dilution to shareholders one might normally expect,…

WednesdayFeb 15, 2023 11:48 am

QualityStocksNewsBreaks – Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Complete Road Construction, Start Drilling at the Western Target

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF), based in Arizona and focused on copper and gold exploration, announced that it has completed road construction to the first of two drill pads at the Western Target of the company’s Kay Mine Project. According to the announcement, these pads will allow for testing of the Western Target and drilling of anomalies located between the Central and Western Targets. In the announcement, the company also noted that the Central Target is thought to be a structural repetition of the Kay Mine Deposit horizon. As of Sept. 2022, Arizona Metals has $58 million in…

WednesdayFeb 15, 2023 11:13 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Q1 2023 Fiscal, Business Report

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on its fiscal first quarter for the period ending Dec. 31, 2022. Highlights of the report include the following: acquiring the assets of Electric Last Mile Solutions (“ELMS”) in a $105 million acquisition move; $100 million in cash being available for operations and investment at the end of Q1 2023; 31, 2022; securing the rights for exclusive sales, distribution and branding for the new compact electric vehicle, the Mullen-GO (formerly I-GO), and initial delivery of the vehicle to the distribution agent; receiving a $200 million purchase order from…

WednesdayFeb 15, 2023 10:56 am

QualityStocksNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Report, Corporate Update for Q3

India Globalization Capital (NYSE American: IGC) (dba IGC Inc.) is reporting on its financial and corporate performance for the third fiscal quarter 2023. Highlights of the report include a focus on the company’s phase 2 clinical trial on IGC-AD1 for agitation in dementia from Alzheimer’s disease. The company reports that the number of sites participating in the trial has reached four: three sites in the United States and one site in Canada. In addition, based on patient enrollment and interest in the study, the company plans to more than double the number of trial sites, from the planned 4 or…

TuesdayFeb 14, 2023 12:51 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q4 and FY 2022 Financial Results, Earnings Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that it will provide a business update and release its financial results for the fourth quarter and full year 2022 following the close of the market on Tuesday, March 14, 2023. Cepton will host a conference call and webcast at 2:30 p.m. PT (5:30 p.m. ET) that same day. Interested parties may join the call by dialing 1-877-300-8521 (toll-free) or 1-412-317-6026 (international) and visiting Cepton’s Investor Relations page to access the live webcast. A telephonic replay will be available approximately two hours after the live…

TuesdayFeb 14, 2023 11:50 am

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms US-Based Subsidiary with Focus to Expand Innovation Platforms

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the formation of a U.S.-based wholly owned subsidiary, Pearsanta Inc. The move intends to accelerate the expansion of Aditxt’s second program, AditxtScore(TM), through future strategic revenue and growth-oriented transactions. According to the update, Anthony Voorhies, currently the head of the AditxtScore(TM) division, will serve as president of Pearsanta. Voorhies has over 20 years of clinical diagnostics and healthtech industry experience and, under his leadership, the AditxtScore(TM) division has successfully grown from inception to commercialization and revenues in just…

TuesdayFeb 14, 2023 11:27 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Q3 Financial Report, Corporate Highlights

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is reporting on its third quarter performance as well as recent business highlights; the report is for the period ended Dec. 31, 2022. In the report, the company noted that it had received approval from an independent ethics committee in the Netherlands to begin the first-in-human dosing of its CYB004 through a protocol amendment to its ongoing phase 1 CYB004-E trial; CYB004 is the company’s proprietary deuterated N,N-dimethyltryptamine (“DMT”) molecule. The company is also making progress on its phase 1/2a clinical trial evaluating CYB003 for the potential treatment…

Site Search

Company Search

Category: QualityStocksNewsBreaks